Abstract
Background: Patients with low calcium scores (CS) considered to be at low risk for cardiac events are often reassured, and not usually considered for lipid lowering therapy. A low CS, however, does not preclude the finding of non-calcified plaque (NCP) and even ischaemia. The earlier detection of NCP by newer generation MDCT systems may play an increasing role in more accurately determining true cardiac risk by providing a more reliable estimation of overall plaque burden beyond the mere assessment of calcium.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
